Welcome to our dedicated page for MACERICH CO SEC filings (Ticker: MAC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on MACERICH CO's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into MACERICH CO's regulatory disclosures and financial reporting.
Lowenthal Marianne reported acquisition or exercise transactions in this Form 4 filing.
Macerich Company director Marianne Lowenthal received a grant of 6,720 shares of Common Stock as non-cash compensation. The award was in the form of restricted stock units under The Macerich Company 2003 Equity Incentive Plan and carries a zero dollar grant price. The restricted stock units vest one year after the award date of 2026-06-01. Following this grant, Lowenthal directly holds 43,596 shares of Macerich common stock.
Murphy Devin Ignatius reported acquisition or exercise transactions in this Form 4 filing.
MACERICH CO director Devin Ignatius Murphy reported a stock-based compensation grant rather than a market purchase. He received 6,720 shares of common stock in the form of restricted stock units under The Macerich Company 2003 Equity Incentive Plan, at no cash cost, which vest one year after the award date. Following this grant, he holds 24,621 shares of common stock directly, including 414 previously unreported restricted stock units credited as dividend equivalents under the plan’s deferral feature.
Hirsch Daniel J. reported acquisition or exercise transactions in this Form 4 filing.
MACERICH CO director Daniel J. Hirsch received a non-cash award of 6,720 restricted stock units of Common Stock under The Macerich Company 2003 Equity Incentive Plan. These units vest one year after the award date. Following the award, he directly holds 91,898 shares and indirectly holds 4,732 shares through a family trust.
Hash Steve reported acquisition or exercise transactions in this Form 4 filing.
MACERICH CO director Steve Hash received a grant of 9,520 shares of Common Stock as restricted stock units, awarded as non-cash compensation under The Macerich Company 2003 Equity Incentive Plan.
The restricted stock units vest one year after the award date. Following this grant and prior credited units, Hash now holds 156,153 shares directly, including 4,876 restricted stock units credited as dividend equivalents under the plan’s deferral feature.
The Macerich Company filed an 8-K to furnish a new investor presentation updating its Path Forward Plan and long-term outlook. The deck highlights a Class A–focused mall portfolio, progress on deleveraging, and a substantial leasing and redevelopment pipeline intended to support future growth.
The Go-Forward Portfolio generated sales of $941 per square foot and averages seven annual visits per center, with roughly 90% of NOI coming from Class A properties. Management reports record leasing in 2025, an in-place Signed Not Open pipeline of about $120 million of incremental annual revenue and a goal of roughly $140 million. Pro forma leverage has been reduced by 1.5x from 8.76x at year-end 2023 to 7.76x net debt to EBITDA as of March 31, 2026, with a stated target of about 6.0x.
The presentation outlines illustrative 2028 Pro Forma NOI for the Go-Forward Portfolio in a range of $950–$990 million and a 2028 target FFO per share between $1.80 and $2.00, based on approximately 300 million shares. Macerich also notes about $1.3 billion of completed asset sales, a further $300–$400 million of anticipated 2026 dispositions, and a $900 million revolving credit facility contributing to roughly $1.2 billion of available liquidity.
The Macerich Company completed a common stock offering, issuing and selling 22,080,000 shares at a public offering price of $21.00 per share under an underwriting agreement with Goldman Sachs & Co. LLC and other underwriters. The underwriters’ 30-day option to purchase up to an additional 2,880,000 shares of common stock was exercised in full.
The company will contribute the net proceeds to The Macerich Partnership, L.P. in exchange for securities with economic interests similar to the common stock. The operating partnership intends to use the net proceeds to repay borrowings under the company’s revolving credit facility, which were used primarily to fund the acquisition of Annapolis Mall, and for general corporate purposes including acquiring additional properties and funding strategic leasing capital investments at Annapolis Mall, with any interim funds held in short-term, interest-bearing deposits.
The Macerich Company is offering $21.00 per share for 19,200,000 shares of common stock, with an underwriter option for an additional 2,880,000 shares. Proceeds will be contributed to the Operating Partnership and are intended principally to repay borrowings under the revolving credit facility and for general corporate purposes.
The offering is structured as a primary sale of common stock and the shares are expected to be delivered on or about May 13, 2026. The prospectus supplement discloses underwriting arrangements, lock‑ups, and international selling restrictions.
The Macerich Company is offering 16,000,000 shares of its common stock in a registered public offering, subject to completion. The prospectus supplement dated May 11, 2026 states the shares will be offered at a public offering price and that the underwriters have a 30-day option to purchase up to an additional 2,400,000 shares. The company says net proceeds are expected to be contributed to its Operating Partnership and used to repay borrowings under its revolving credit facility (which had $250.0 million outstanding as of May 8, 2026) and for general corporate purposes, including investments at Annapolis Mall.
MACERICH CO reports that FMR LLC (with Abigail P. Johnson listed) beneficially owns 26,502,907.21 shares of Common Stock, representing 10.2% of the class. The filing lists sole dispositive power of 26,502,907.21 shares and sole voting power of 25,934,014.64 shares. The disclosure is an amendment to a Schedule 13G filing and references Exhibit 99 and an attached power of attorney.
The Macerich Company reported a smaller net loss for Q1 2026 while reshaping its mall portfolio and balance sheet. Total revenues were $241.5 million versus $249.2 million a year earlier, as leasing revenue declined modestly. Net loss attributable to the company improved to $36.4 million, or $0.14 per share, compared with a $50.1 million loss, or $0.20 per share, in Q1 2025, helped by lower depreciation, interest expense and a $6.8 million net gain on property and land sales.
Cash from operating activities was $77.4 million, down from $88.5 million, while cash, cash equivalents and restricted cash totaled $270.8 million at quarter‑end. Macerich strengthened liquidity by upsizing and extending its revolving credit facility to $900 million, with $799.4 million of availability, and by raising about $65.5 million of net equity through its at‑the‑market program. The company continued its capital recycling, investing in redevelopment projects and, after quarter‑end, acquiring Annapolis Mall and an adjacent parcel for $272 million funded with cash and credit facility borrowings.